Clinical Trials on RCC

Total 430 results

SparX Biotech(Jiangsu) Co., Ltd.

Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)

Solid Tumor | CRC | HNSCC | RCC

United States
Harbin Medical University
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

HCC | NSCLC | CRC
RenJi Hospital
Peking University First Hospital; Fudan University; Shanghai Zhongshan Hospital; First Affiliated Hospital, Sun Yat-Sen University and other collaborators

Recruiting

Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients

Biomarkers | FH-Deficient RCC | Systemic Treatments

China
Seton Healthcare Family
University of Texas at Austin; Dell Medical School at The University of Texas...

Withdrawn

Intraoperative Margin Assessment During Mohs Surgery

Basal Cell Carcinoma (BCC) | Squamous Cell Carcinoma (SCC)
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Melanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCC

Korea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
Qianfoshan Hospital

Not yet recruiting

Study of Serum Tumor Markers of HBV Associated HCC

HCC
University of Pisa
Azienda Ospedaliera Città della Salute e della Scienza di Torino; Fondazione... and other collaborators

Recruiting

Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC (SEASON-HCC)

HCC

Italy
Chinese University of Hong Kong

Withdrawn

Effect of WhatsApp Messenger on Uptake of CRC Screening Study

CRC

Hong Kong
Seoul National University Hospital
Philips Healthcare

Completed

"Double Low-Dose" DECT for HCC Imaging

HCC

Korea, Republic of
Huazhong University of Science and Technology

Unknown

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

HCC

China
Motus GI Medical Technologies Ltd

Completed

Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System

CRC

Israel
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

CRC

Spain
Taipei Medical University WanFang Hospital

Terminated

Statin With Palliative Therapy for HCC

HCC

Taiwan
Leiden University Medical Center
Medtronic; ZonMw: The Netherlands Organisation for Health Research and Development and other collaborators

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

HCC | Early Stage HCC

Netherlands
University of Minnesota

Active, not recruiting

Clinical Impact of Red Cell Storage Age

RBC Transfusions

United States
Qianfoshan Hospital

Not yet recruiting

Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC

HCC
Xuhua Duan

Recruiting

DEB-TACE Versus DEB-TACE Sequential HAIC for Unresectable BCLC Stage C HCC; A Randomized Controlled Trial

HCC

China
Motus GI Medical Technologies Ltd

Terminated

Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation

CRC

Israel
Ain Shams University

Completed

Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria

Hcc
Access Vascular Inc

Completed

A Comparative, Retrospective Chart Review of Intended Dwell Time of a PICC Line

PICC | Peripheral ICC

United States
Shenyang Tenth People's Hospital
Beijing Tsinghua Changgeng Hospital

Not yet recruiting

Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC

Advanced HCC
Assiut University

Not yet recruiting

Impact of Lecuofiltration of Packed Red Blood Cells on Different Hematological Parameters Measured by Advia 2120

Leucodepletion of Packed RBC
jianming xu
KAEDI

Recruiting

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Solid Tumor | CRC

China
Ain Shams University

Completed

TAURINE and HCC PATIENTS

Taurine in HCC

Egypt
Letolab

Not yet recruiting

Phase II Clinical Study of LTC004 in Patients With mCRC

Locally Advanced or Metastatic CRC
Seoul National University Hospital
Bayer

Completed

Added Value of Gadoxetic Acid-enhanced Liver MRI

Diagnosis | Hcc

Korea, Republic of
Chen Xiaoping

Not yet recruiting

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

HCC
Henan Cancer Hospital

Not yet recruiting

Tace With Icaritin in First-line Treatment of Middle and Advanced HCC in Child Grade B Patients

HCC
Shanghai Henlius Biotech

Not yet recruiting

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

CRC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Regina Elena Cancer Institute

Recruiting

Accurate Dosimetry and Biomarkers Improve Survival in HCC Patients Treated With Resin 90 Yttrium (90Y)-Microspheres (DOSEY90)

HCC

Italy
The First Affiliated Hospital of Zhengzhou University

Unknown

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

HCC

China
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Performance of the Motus Cleansing System (MCS) (MCS)

CRC

Netherlands, Germany
feng xiaobin

Unknown

ERAS Program Improves Recovery of HCC Patient Undergoing Hepatectomy

HCC

China
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus GI CleanUp System During Screening Colonoscopy

CRC
Calithera Biosciences, Inc

Terminated

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Clear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCC

United States
Tang-Du Hospital
Xijing Hospital; Sun Yat-sen University; Shaanxi Provincial People's Hospital; Air... and other collaborators

Completed

A New Conception About Individualized Treatment Allocation for HCC (PTA4HCC)

HCC | Resection | Transarterial Chemoembolization
The Netherlands Cancer Institute
Erasmus Medical Center; Amsterdam University Medical Centres (AUMC)

Active, not recruiting

Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening (mtFIT)

CRC | Advanced Neoplasia

Netherlands
University of Bologna
University of Pisa; Azienda Ospedaliera Città della Salute e della Scienza... and other collaborators

Completed

Equity and Efficacy of Allocation Priority for Liver Transplantation Patients With MELD≥30 in Italy

HCC | Liver Transplant Disorder
Jacobio Pharmaceuticals Co., Ltd.

Recruiting

JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

NSCLC | Advanced Solid Tumor | CRC

United States
University of Florida

Not yet recruiting

Virtual Planning of ALT Flap

Tongue SCC
Teleflex
Duke University

Enrolling by invitation

Vascular Positioning System G4 Algorithm ECG Data Collection for Model Training Study

Peripheral ICC

United States
Jacobio Pharmaceuticals Co., Ltd.

Recruiting

FIH Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation in China

NSCLC | Solid Tumor | CRC

China
The University of Hong Kong
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy (START-FIT)

HCC

Hong Kong
Seoul National University Hospital
Taejoon Pharmaceutical Co., Ltd.; Reyon Pharmaceutical Co., Ltd.

Completed

A Study of HCC High Risk Group Using Two Surveillance Tools

HCC

Korea, Republic of
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC (LCRAI-1)

HCC
Incyte Corporation

Recruiting

Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors

Melanoma | Hepatocellular Carcinoma (HCC) | Renal Cell Carcinoma (RCC) | Colorectal Carcinoma (CRC) | Microsatellite Instability - High (MSI-H) | Mismatch Repair Deficient (dMMR)

United States, Brazil, Canada, Australia, Slovakia, Norway, Mexico
Incyte Corporation

Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Head and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)

Italy, Spain, United States, Netherlands
Shanghai Kanda Biotechnology Co., Ltd.

Not yet recruiting

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Other Solid Tumors | Advanced HCC

China
InventisBio Co., Ltd
Merck Sharp & Dohme LLC

Active, not recruiting

Study to Evaluate D-1553 in Subjects With Solid Tumors

NSCLC | Solid Tumor, Adult | CRC

United States, Taiwan, Australia, Korea, Republic of
Valérie LAURENT

Completed

CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy

Advanced HCC Treated by Systemic Immunotherapy

France

Clinical Trials on RCC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations